# The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients

> **NCT01005095** · PHASE4 · TERMINATED · sponsor: **Carmel Medical Center** · enrollment: 45 (actual)

## Conditions studied

- MULTIPLE SCLEROSIS

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin D3
- **DIETARY_SUPPLEMENT:** Vitamin D3

## Key facts

- **NCT ID:** NCT01005095
- **Lead sponsor:** Carmel Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Interim analysis showed that the odds for proving primary hypothesis are low.
- **Last updated:** 2012-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005095, "The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01005095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*